Insider trade

Director sold ~$308K of BCPC shares in the open market

Traded Dec 3, 2025 · Filed Dec 5, 2025

Why it stands out

A board member of Balchem sold $308K of Balchem shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Director$100K–$500K

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$308,291

Shares × reported transaction price

Timing vs results

43 days after results of Oct 21, 2025, 79 days before results of Feb 20, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+7.7%	−0.4%	+8.1%
30 days	+5.0%	+0.9%	+4.1%
90 days	+17.2%	−0.8%	+17.9%
180 days	+7.7%	+8.1%	−0.4%

Past results only. Not a forecast.

This transaction was executed in multiple sales ranging from $153.9045 to $154.3400 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.